相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting both BET and CBP/EP300 proteins with the novel dual inhibitors NEO2734 and NEO1132 leads to anti-tumor activity in multiple myeloma
Katie R. Ryan et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance
Joshi J. Alumkal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734
Chevaun D. Morrison-Smiths et al.
MOLECULAR CANCER THERAPEUTICS (2020)
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer
Laura Cato et al.
CANCER CELL (2019)
Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naive Primary Prostate Cancer
Daniel E. Spratt et al.
CLINICAL CANCER RESEARCH (2019)
The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer
Yuqian Yan et al.
EMBO MOLECULAR MEDICINE (2019)
N-Myc mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
Adeline Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
Mark P. Labrecque et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
ONECUT2 is a driver of neuroendocrine prostate cancer
Haiyang Guo et al.
NATURE COMMUNICATIONS (2019)
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
David A. Quigley et al.
CELL (2018)
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer
David Y. Takeda et al.
CELL (2018)
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing
Srinivas R. Viswanathan et al.
CELL (2018)
Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer
Yundong He et al.
NUCLEIC ACIDS RESEARCH (2018)
DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants
Chao Xu et al.
STRUCTURE (2018)
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
Qiuhui Li et al.
NATURE COMMUNICATIONS (2018)
429PNEO2734: A novel potent oral dual BET and P300/CBP inhibitor
F Giles et al.
ANNALS OF ONCOLOGY (2018)
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
Mirja Rotinen et al.
NATURE MEDICINE (2018)
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
Jennifer L. Bishop et al.
CANCER DISCOVERY (2017)
Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs
Shixin Ma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Eric G. Bluemn et al.
CANCER CELL (2017)
Ever-Changing Landscapes: Transcriptional Enhancers in Development and Evolution
Hannah K. Long et al.
CELL (2016)
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Akash Kumar et al.
NATURE MEDICINE (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Organoid culture systems for prostate epithelial and cancer tissue
Jarno Drost et al.
NATURE PROTOCOLS (2016)
Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)
Alexander M. Taylor et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer
Yundong He et al.
NATURE COMMUNICATIONS (2016)
Evolutionary changes in promoter and enhancer activity during human corticogenesis
Steven K. Reilly et al.
SCIENCE (2015)
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
David T. Miyamoto et al.
SCIENCE (2015)
Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes lung cancer growth and metastasis
Yun-Neng Tang et al.
NATURE COMMUNICATIONS (2015)
Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy
Manish Kohli et al.
PLOS ONE (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Irfan A. Asangani et al.
NATURE (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
STEME: A Robust, Accurate Motif Finder for Large Data Sets
John E. Reid et al.
PLOS ONE (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
ZF-CxxC domain-containing proteins, CpG islands and the chromatin connection
Hannah K. Long et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
Vivek K. Arora et al.
CELL (2013)
Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX
Myunggon Ko et al.
NATURE (2013)
A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509
James D. Joseph et al.
CANCER DISCOVERY (2013)
ID1 and ID3 Regulate the Self-Renewal Capacity of Human Colon Cancer-Initiating Cells through p21
Catherine A. O'Brien et al.
CANCER CELL (2012)
The long-range interaction landscape of gene promoters
Amartya Sanyal et al.
NATURE (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
Keith F. Decker et al.
NUCLEIC ACIDS RESEARCH (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1
Changmeng Cai et al.
CANCER CELL (2011)
CpG islands and the regulation of transcription
Aimee M. Deaton et al.
GENES & DEVELOPMENT (2011)
Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA
Dong Wang et al.
NATURE (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
STEME: efficient EM to find motifs in large data sets
John E. Reid et al.
NUCLEIC ACIDS RESEARCH (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
Sven Heinz et al.
MOLECULAR CELL (2010)
GREAT improves functional interpretation of cis-regulatory regions
Cory Y. McLean et al.
NATURE BIOTECHNOLOGY (2010)
Jarid2/Jumonji Coordinates Control of PRC2 Enzymatic Activity and Target Gene Occupancy in Pluripotent Cells
Jamy C. Peng et al.
CELL (2009)
High Levels of Id1 Expression Define B1 Type Adult Neural Stem Cells
Hyung-song Nam et al.
CELL STEM CELL (2009)
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription
Mathieu Lupien et al.
CELL (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
Profilin2 contributes to synaptic vesicle exocytosis, neuronal excitability, and novelty-seeking behavior
Pietro Pilo Boyl et al.
EMBO JOURNAL (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis
S Fong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Id2 regulates angiogenesis through transcriptional repression of thrombospondin-1
OV Volpert et al.
CANCER CELL (2002)
Androgen receptor signaling in androgen-refractory prostate cancer
ME Grossmann et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
分享论文
